ntic20220531_10q.htm
0000875582 Northern Technologies International Corporation false --08-31 Q3 2022 382,000 382,000 0 0 10,000 10,000 0 0 0 0 0.02 0.02 15,000,000 15,000,000 9,232,483 9,232,483 9,184,811 9,184,811 15.3 15 50 423,000 423,000 423,000 423,000 1.10 0 0 72,418 0 0 327,793 136,221 10 1 3 Includes Zerust India since Zerust India was not a consolidated subsidiary of the Company as of August 31, 2021 or May 31, 2021. See Note 3 entitled “Business Combination.” The percent of segment sales is calculated by dividing the direct cost of goods sold for each individual segment category by the net sales for each segment category. 00008755822021-09-012022-05-31 xbrli:shares 00008755822022-07-08 iso4217:USD 00008755822022-05-31 00008755822021-08-31 0000875582ntic:PatentsAndTrademarksMember2022-05-31 0000875582ntic:PatentsAndTrademarksMember2021-08-31 0000875582ntic:IntangibleAssetsExcludingPatentsAndTrademarksMember2022-05-31 0000875582ntic:IntangibleAssetsExcludingPatentsAndTrademarksMember2021-08-31 iso4217:USDxbrli:shares 00008755822022-03-012022-05-31 00008755822021-03-012021-05-31 00008755822020-09-012021-05-31 0000875582us-gaap:CommonStockMember2022-02-28 0000875582us-gaap:AdditionalPaidInCapitalMember2022-02-28 0000875582us-gaap:RetainedEarningsMember2022-02-28 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-02-28 0000875582us-gaap:NoncontrollingInterestMember2022-02-28 00008755822022-02-28 0000875582us-gaap:CommonStockMember2022-03-012022-05-31 0000875582us-gaap:AdditionalPaidInCapitalMember2022-03-012022-05-31 0000875582us-gaap:RetainedEarningsMember2022-03-012022-05-31 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-012022-05-31 0000875582us-gaap:NoncontrollingInterestMember2022-03-012022-05-31 0000875582us-gaap:CommonStockMember2022-05-31 0000875582us-gaap:AdditionalPaidInCapitalMember2022-05-31 0000875582us-gaap:RetainedEarningsMember2022-05-31 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-05-31 0000875582us-gaap:NoncontrollingInterestMember2022-05-31 0000875582us-gaap:CommonStockMember2021-02-28 0000875582us-gaap:AdditionalPaidInCapitalMember2021-02-28 0000875582us-gaap:RetainedEarningsMember2021-02-28 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-02-28 0000875582us-gaap:NoncontrollingInterestMember2021-02-28 00008755822021-02-28 0000875582us-gaap:CommonStockMember2021-03-012021-05-31 0000875582us-gaap:AdditionalPaidInCapitalMember2021-03-012021-05-31 0000875582us-gaap:RetainedEarningsMember2021-03-012021-05-31 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-012021-05-31 0000875582us-gaap:NoncontrollingInterestMember2021-03-012021-05-31 0000875582us-gaap:CommonStockMember2021-05-31 0000875582us-gaap:AdditionalPaidInCapitalMember2021-05-31 0000875582us-gaap:RetainedEarningsMember2021-05-31 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-05-31 0000875582us-gaap:NoncontrollingInterestMember2021-05-31 00008755822021-05-31 0000875582us-gaap:CommonStockMember2021-08-31 0000875582us-gaap:AdditionalPaidInCapitalMember2021-08-31 0000875582us-gaap:RetainedEarningsMember2021-08-31 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-08-31 0000875582us-gaap:NoncontrollingInterestMember2021-08-31 0000875582us-gaap:CommonStockMember2021-09-012022-05-31 0000875582us-gaap:AdditionalPaidInCapitalMember2021-09-012022-05-31 0000875582us-gaap:RetainedEarningsMember2021-09-012022-05-31 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-012022-05-31 0000875582us-gaap:NoncontrollingInterestMember2021-09-012022-05-31 0000875582us-gaap:CommonStockMember2020-08-31 0000875582us-gaap:AdditionalPaidInCapitalMember2020-08-31 0000875582us-gaap:RetainedEarningsMember2020-08-31 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-08-31 0000875582us-gaap:NoncontrollingInterestMember2020-08-31 00008755822020-08-31 0000875582us-gaap:CommonStockMember2020-09-012021-05-31 0000875582us-gaap:AdditionalPaidInCapitalMember2020-09-012021-05-31 0000875582us-gaap:RetainedEarningsMember2020-09-012021-05-31 0000875582us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-012021-05-31 0000875582us-gaap:NoncontrollingInterestMember2020-09-012021-05-31 xbrli:pure 0000875582ntic:HaritaNTILimitedMember2021-09-01 0000875582ntic:HaritaNTILimitedMember2021-09-012021-09-01 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2021-09-01 0000875582ntic:HaritaNTILimitedMemberus-gaap:CustomerRelationshipsMember2021-09-01 0000875582ntic:HaritaNTILimitedMemberus-gaap:CustomerRelationshipsMember2021-09-012021-09-01 utr:Y 0000875582ntic:HaritaNTILimitedMemberntic:CustomerRelationshipsAndAssembledWorkforceMember2021-09-012021-09-01 0000875582ntic:HaritaNTILimitedMember2021-09-012022-05-31 0000875582ntic:HaritaNTILimitedMember2022-03-012022-05-31 0000875582ntic:HaritaNTILimitedMember2021-03-012021-05-31 0000875582ntic:HaritaNTILimitedMember2020-09-012021-05-31 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-05-31 0000875582ntic:EXCORMember2022-05-31 0000875582ntic:AllOtherMember2022-05-31 0000875582ntic:EXCORAndAllOtherJointVentursMember2022-05-31 0000875582ntic:EXCORMember2022-05-31 0000875582ntic:AllOtherMember2022-05-31 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-03-012022-05-31 0000875582ntic:EXCORMember2022-03-012022-05-31 0000875582ntic:AllOtherMember2022-03-012022-05-31 0000875582ntic:EXCORAndAllOtherJointVentursMember2022-03-012022-05-31 0000875582ntic:EXCORMember2022-03-012022-05-31 0000875582ntic:AllOtherMember2022-03-012022-05-31 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-09-012022-05-31 0000875582ntic:EXCORMember2021-09-012022-05-31 0000875582ntic:JointVenturesInFranceMember2021-09-012022-05-31 0000875582ntic:EXCORAndAllOtherJointVentursMember2021-09-012022-05-31 0000875582ntic:EXCORMember2021-09-012022-05-31 0000875582ntic:JointVenturesInFranceMember2021-09-012022-05-31 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-08-31 0000875582ntic:EXCORMember2021-08-31 0000875582ntic:JointVenturesInFranceMember2021-08-31 0000875582ntic:EXCORAndAllOtherJointVentursMember2021-08-31 0000875582ntic:EXCORMember2021-08-31 0000875582ntic:JointVenturesInFranceMember2021-08-31 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-03-012021-05-31 0000875582ntic:EXCORMember2021-03-012021-05-31 0000875582ntic:JointVenturesInFranceMember2021-03-012021-05-31 0000875582ntic:EXCORAndAllOtherJointVentursMember2021-03-012021-05-31 0000875582ntic:EXCORMember2021-03-012021-05-31 0000875582ntic:JointVenturesInFranceMember2021-03-012021-05-31 0000875582us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2020-09-012021-05-31 0000875582ntic:EXCORMember2020-09-012021-05-31 0000875582ntic:JointVenturesInFranceMember2020-09-012021-05-31 0000875582ntic:EXCORAndAllOtherJointVentursMember2020-09-012021-05-31 0000875582ntic:EXCORMember2020-09-012021-05-31 0000875582ntic:JointVenturesInFranceMember2020-09-012021-05-31 0000875582us-gaap:CustomerRelationshipsMember2022-05-31 0000875582us-gaap:CustomerRelationshipsMember2021-08-31 0000875582ntic:CustomerRelationshipsAndAssembledWorkforceMember2021-12-012022-05-31 0000875582ntic:CustomerRelationshipsAndAssembledWorkforceMember2022-03-012022-05-31 0000875582ntic:CustomerRelationshipsAndAssembledWorkforceMember2021-09-012022-05-31 0000875582ntic:CustomerRelationshipsAndAssembledWorkforceMember2022-05-31 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2022-05-31 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMembersrt:ScenarioForecastMember2022-08-16 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-09-012022-05-31 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2022-02-22 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2022-04-23 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2021-08-31 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2022-03-012022-05-31 0000875582us-gaap:RevolvingCreditFacilityMemberntic:PNCBankMember2021-09-012022-05-31 0000875582ntic:JPMorganChaseBankMember2022-05-31 0000875582ntic:JPMorganChaseBankMember2021-08-31 00008755822021-10-202021-10-20 thunderdome:item 00008755822022-01-212022-01-21 00008755822022-04-222022-04-22 00008755822021-01-152021-01-15 00008755822021-04-232021-04-23 0000875582ntic:The2019PlanMemberntic:EmployeesAndDirectorsMember2021-09-012022-05-31 0000875582ntic:The2019PlanMemberntic:EmployeesAndDirectorsMember2020-09-012021-05-31 00008755822021-09-012021-09-01 00008755822020-09-012020-09-01 00008755822022-03-012022-03-01 00008755822021-03-012021-03-01 0000875582ntic:ESPPMember2021-05-31 0000875582us-gaap:EmployeeStockOptionMember2022-03-012022-05-31 0000875582us-gaap:EmployeeStockOptionMember2021-09-012022-05-31 0000875582us-gaap:EmployeeStockOptionMember2021-03-012021-05-31 0000875582us-gaap:EmployeeStockOptionMember2020-09-012021-05-31 0000875582ntic:The2019PlanMember2021-01-152021-01-15 0000875582ntic:The2019PlanMember2022-05-31 0000875582ntic:The2019PlanMember2021-09-012022-05-31 0000875582ntic:The2019PlanMembersrt:MinimumMemberntic:OneYearAfterDateOfGrantMember2021-09-012022-05-31 0000875582ntic:The2019PlanMembersrt:MaximumMemberntic:OneYearAfterDateOfGrantMember2021-09-012022-05-31 0000875582ntic:The2007PlanMember2022-05-31 0000875582ntic:ZERUSTMember2022-03-012022-05-31 0000875582ntic:ZERUSTMember2021-03-012021-05-31 0000875582ntic:ZERUSTMember2021-09-012022-05-31 0000875582ntic:ZERUSTMember2020-09-012021-05-31 0000875582ntic:NaturTecMember2022-03-012022-05-31 0000875582ntic:NaturTecMember2021-03-012021-05-31 0000875582ntic:NaturTecMember2021-09-012022-05-31 0000875582ntic:NaturTecMember2020-09-012021-05-31 0000875582ntic:DirectCostOfGoodsSoldMemberntic:ZERUSTMember2022-03-012022-05-31 0000875582ntic:DirectCostOfGoodsSoldMemberntic:ZERUSTMember2021-03-012021-05-31 0000875582ntic:DirectCostOfGoodsSoldMemberntic:ZERUSTMember2021-09-012022-05-31 0000875582ntic:DirectCostOfGoodsSoldMemberntic:ZERUSTMember2020-09-012021-05-31 0000875582ntic:DirectCostOfGoodsSoldMemberntic:NaturTecMember2022-03-012022-05-31 0000875582ntic:DirectCostOfGoodsSoldMemberntic:NaturTecMember2021-03-012021-05-31 0000875582ntic:DirectCostOfGoodsSoldMemberntic:NaturTecMember2021-09-012022-05-31 0000875582ntic:DirectCostOfGoodsSoldMemberntic:NaturTecMember2020-09-012021-05-31 0000875582ntic:IndirectCostOfGoodsSoldMember2022-03-012022-05-31 0000875582ntic:IndirectCostOfGoodsSoldMember2021-03-012021-05-31 0000875582ntic:IndirectCostOfGoodsSoldMember2021-09-012022-05-31 0000875582ntic:IndirectCostOfGoodsSoldMember2020-09-012021-05-31 0000875582ntic:InsideTheUSAToUnaffiliatedCustomersMember2022-03-012022-05-31 0000875582ntic:InsideTheUSAToUnaffiliatedCustomersMember2021-03-012021-05-31 0000875582ntic:InsideTheUSAToUnaffiliatedCustomersMember2021-09-012022-05-31 0000875582ntic:InsideTheUSAToUnaffiliatedCustomersMember2020-09-012021-05-31 0000875582ntic:JointVenturesInWhichTheCompanyIsAShareholderDirectlyAndIndirectlyOutsideTheUSAMember2022-03-012022-05-31 0000875582ntic:JointVenturesInWhichTheCompanyIsAShareholderDirectlyAndIndirectlyOutsideTheUSAMember2021-03-012021-05-31 0000875582ntic:JointVenturesInWhichTheCompanyIsAShareholderDirectlyAndIndirectlyOutsideTheUSAMember2021-09-012022-05-31 0000875582ntic:JointVenturesInWhichTheCompanyIsAShareholderDirectlyAndIndirectlyOutsideTheUSAMember2020-09-012021-05-31 0000875582ntic:UnaffiliatedCustomersOutsideTheUSAMember2022-03-012022-05-31 0000875582ntic:UnaffiliatedCustomersOutsideTheUSAMember2021-03-012021-05-31 0000875582ntic:UnaffiliatedCustomersOutsideTheUSAMember2021-09-012022-05-31 0000875582ntic:UnaffiliatedCustomersOutsideTheUSAMember2020-09-012021-05-31 0000875582country:DE2022-03-012022-05-31 0000875582country:DE2021-03-012021-05-31 0000875582country:PL2022-03-012022-05-31 0000875582country:PL2021-03-012021-05-31 0000875582country:JP2022-03-012022-05-31 0000875582country:JP2021-03-012021-05-31 0000875582country:FR2022-03-012022-05-31 0000875582country:FR2021-03-012021-05-31 0000875582country:SE2022-03-012022-05-31 0000875582country:SE2021-03-012021-05-31 0000875582country:GB2022-03-012022-05-31 0000875582country:GB2021-03-012021-05-31 0000875582country:TH2022-03-012022-05-31 0000875582country:TH2021-03-012021-05-31 0000875582country:FI2022-03-012022-05-31 0000875582country:FI2021-03-012021-05-31 0000875582country:CZ2022-03-012022-05-31 0000875582country:CZ2021-03-012021-05-31 0000875582country:KR2022-03-012022-05-31 0000875582country:KR2021-03-012021-05-31 0000875582ntic:OtherCountriesMember2022-03-012022-05-31 0000875582ntic:OtherCountriesMember2021-03-012021-05-31 0000875582country:DE2021-09-012022-05-31 0000875582country:DE2020-09-012021-05-31 0000875582country:PL2021-09-012022-05-31 0000875582country:PL2020-09-012021-05-31 0000875582country:JP2021-09-012022-05-31 0000875582country:JP2020-09-012021-05-31 0000875582country:FR2021-09-012022-05-31 0000875582country:FR2020-09-012021-05-31 0000875582country:SE2021-09-012022-05-31 0000875582country:SE2020-09-012021-05-31 0000875582country:GB2021-09-012022-05-31 0000875582country:GB2020-09-012021-05-31 0000875582country:TH2021-09-012022-05-31 0000875582country:TH2020-09-012021-05-31 0000875582country:FI2021-09-012022-05-31 0000875582country:FI2020-09-012021-05-31 0000875582country:CZ2021-09-012022-05-31 0000875582country:CZ2020-09-012021-05-31 0000875582country:KR2021-09-012022-05-31 0000875582country:KR2020-09-012021-05-31 0000875582ntic:OtherCountriesMember2021-09-012022-05-31 0000875582ntic:OtherCountriesMember2020-09-012021-05-31 0000875582country:CN2022-05-31 0000875582country:CN2021-08-31 0000875582ntic:OtherCountriesMember2022-05-31 0000875582ntic:OtherCountriesMember2021-08-31 0000875582country:US2022-05-31 0000875582country:US2021-08-31 0000875582country:CN2022-03-012022-05-31 0000875582country:CN2021-03-012021-05-31 0000875582country:CN2021-09-012022-05-31 0000875582country:CN2020-09-012021-05-31 0000875582country:BR2022-03-012022-05-31 0000875582country:BR2021-03-012021-05-31 0000875582country:BR2021-09-012022-05-31 0000875582country:BR2020-09-012021-05-31 0000875582country:IN2022-03-012022-05-31 0000875582country:IN2021-03-012021-05-31 0000875582country:IN2021-09-012022-05-31 0000875582country:IN2020-09-012021-05-31 0000875582country:US2022-03-012022-05-31 0000875582country:US2021-03-012021-05-31 0000875582country:US2021-09-012022-05-31 0000875582country:US2020-09-012021-05-31 0000875582ntic:Fiscal2018BonusPlanMembersrt:ExecutiveOfficerMember2021-09-012022-05-31 0000875582ntic:PatentsAndTrademarksMember2021-09-012022-05-31 0000875582ntic:FeesForServicesProvidedToJointVenturesMember2021-09-012022-05-31
 

         

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________

 

FORM 10-Q

 

(Mark One)

   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 31, 2022

or

   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to __________________

 

Commission File Number: 001-11038

____________________

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation or organization)

41-0857886

(I.R.S. Employer Identification No.)

 

4201 Woodland Road

P.O. Box 69

Circle Pines, Minnesota 55014

(Address of principal executive offices) (Zip Code)  

 

(763) 225-6600
(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.02 per share

NTIC

Nasdaq Global Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer

Smaller reporting company 

 Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No ☒

 

As of July 8, 2022, there were 9,232,483 shares of common stock of the registrant outstanding.

 

 

 
 
 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION

FORM 10-Q

May 31, 2022

 

TABLE OF CONTENTS

 

Description

 

Page

     

PART IFINANCIAL INFORMATION

 

Item 1.

Financial Statements

 
 

Consolidated Balance Sheets as of May 31, 2022 (unaudited) and August 31, 2021

3

  Consolidated Statements of Operations (unaudited) for the Three and Nine Months Ended May 31, 2022 and 2021

4

 

Consolidated Statements of Comprehensive Income (unaudited) for the Three and  Nine Months Ended May 31, 2022 and 2021

5

  Consolidated Statements of Equity (unaudited) for the Three and Nine Months Ended May 31, 2022 and 2021

6

 

Consolidated Statements of Cash Flows (unaudited) for the Nine Months Ended  May 31, 2022 and 2021

7

 

Notes to Consolidated Financial Statements (unaudited)

8

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

21

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

37

Item 4.

Controls and Procedures

37

PART IIOTHER INFORMATION

 

Item 1.

Legal Proceedings

38

Item 1A.

Risk Factors

38

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

39

Item 3.

Defaults Upon Senior Securities

39

Item 4.

Mine Safety Disclosures

40

Item 5.

Other Information

40

Item 6.

Exhibits

40

SIGNATURES

40

 

 


 

 

1

 

 

 

This quarterly report on Form 10-Q contains certain forward-looking statements that are within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created by those sections. For more information, see Part I. Financial Information Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements.

 

 

 


 

As used in this report, references to NTIC, the Company, we, our or us, unless the context otherwise requires, refer to Northern Technologies International Corporation and its wholly-owned and majority-owned subsidiaries, all of which are consolidated on NTICs consolidated financial statements.

 

As used in this report, references to: (1) NTIC China refer to NTICs wholly-owned subsidiary in China, NTIC (Shanghai) Co., Ltd.; (2) NTI Europe refer to NTICs wholly-owned subsidiary in Germany, NTIC Europe GmbH; (3) Zerust Mexico refer to NTICs wholly-owned subsidiary in Mexico, ZERUST-EXCOR MEXICO, S. de R.L. de C.V.; (4) Zerust India refer to NTICs wholly-owned subsidiary in India effective as of September 1, 2021, Harita-NTI Limited; and (5)NTI Asean refer to NTICs majority-owned holding company subsidiary, NTI Asean LLC, which holds investments in certain entities that operate in the Association of Southeast Asian Nations (ASEAN) region.

 

NTICs consolidated financial statements do not include the accounts of any of its joint ventures. Except as otherwise indicated, references in this report to NTICs joint ventures do not include any of NTICs wholly-owned or majority-owned subsidiaries.

 

As used in this report, references to EXCOR refer to NTICs joint venture in Germany, Excor Korrosionsschutz Technologien und Produkte GmbH.

 

All trademarks, trade names or service marks referred to in this report are the property of their respective owners.

 

 

 

 

 

 

 

2

 

PART I - FINANCIAL INFORMATION

 

ITEM 1.         FINANCIAL STATEMENTS

 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS AS OF MAY 31, 2022 (UNAUDITED)

AND AUGUST 31, 2021 (AUDITED)


 

  

May 31, 2022

  

August 31, 2021

 

ASSETS

        

CURRENT ASSETS:

        

Cash and cash equivalents

 $6,123,269  $7,680,641 

Available for sale securities

  5,574   4,634 

Receivables:

        

Trade, excluding joint ventures, less allowance for doubtful accounts of $382,000 as of May 31, 2022 and August 31, 2021

  13,834,580   11,128,805 

Trade, joint ventures

  857,172   624,808 

Fees for services provided to joint ventures

  1,243,214   1,505,127 

Income taxes

  418,967   386,574 

Inventories

  13,866,229   11,114,207 

Prepaid expenses

  2,619,260   1,302,293 

Total current assets

  38,968,265   33,747,089 
         

PROPERTY AND EQUIPMENT, NET

  12,071,277   11,821,458 

OTHER ASSETS:

        

Investments in joint ventures

  22,194,433   27,623,768 

Deferred income taxes

     92,554 

Patents and trademarks, net

  717,795   709,572 

Goodwill

  4,782,376    

Intangible asset, net

  6,029,650    

Operating lease right of use asset

  421,601   376,438 

Total other assets

  34,145,855   28,802,332 

Total assets

 $85,185,397  $74,370,879 
         

LIABILITIES AND EQUITY

        

CURRENT LIABILITIES:

        

Accounts payable

 $6,004,897  $4,290,972 

Line of credit

  4,700,000    

Income taxes payable

  99,865   178,923 

Accrued liabilities:

        

Payroll and related benefits

  2,029,241   2,879,468 

Other

  1,333,153   894,497 

Current portion of operating lease

  74,331   272,336 

Total current liabilities

  14,241,487   8,516,196 

LONG-TERM LIABILITIES:

        

Deferred income tax, net

  1,920,970    

Operating lease, less current portion

  347,270   104,102 

Total long-term liabilities

  2,268,240   104,102 
         

COMMITMENTS AND CONTINGENCIES (Note 14)

          
         

EQUITY:

        

Preferred stock, no par value; authorized 10,000 shares; none issued and outstanding

      

Common stock, $0.02 par value per share; authorized 15,000,000 shares as of May 31, 2022 and August 31, 2021; issued and outstanding 9,232,483 and 9,184,811, respectively

  184,650   183,696 

Additional paid-in capital

  19,706,248   18,736,268 

Retained earnings

  50,714,961   46,973,094 

Accumulated other comprehensive loss

  (5,383,400)  (3,525,030)

Stockholders’ equity

  65,222,459   62,368,028 

Non-controlling interests

  3,453,211   3,382,553 

Total equity

  68,675,670   65,750,581 

Total liabilities and equity

 $85,185,397  $74,370,879 

 

See notes to consolidated financial statements.

 

3

 

 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED MAY 31, 2022 AND 2021


 

   

Three Months Ended May 31,

   

Nine Months Ended May 31,

 
   

2022

   

2021

   

2022

   

2021

 

NET SALES:

                               

Net sales, excluding joint ventures

  $ 18,436,253     $ 14,164,604     $ 51,654,355     $ 38,619,353  

Net sales, to joint ventures

    528,668       1,253,920       2,252,618       2,361,165  

Total net sales

    18,964,921       15,418,524       53,906,973       40,980,518  
                                 

Cost of goods sold

    12,722,833       10,152,582       36,977,620       26,997,582  

Gross profit

    6,242,088       5,265,942       16,929,353       13,982,936  
                                 

JOINT VENTURE OPERATIONS:

                               

Equity in income from joint ventures

    1,364,597       2,033,536       3,662,178       5,779,260  

Fees for services provided to joint ventures

    1,329,988       1,589,621       3,835,755       4,388,866  

Total joint venture operations

    2,694,585       3,623,157       7,497,933       10,168,126  
                                 

OPERATING EXPENSES:

                               

Selling expenses

    3,450,308       3,171,657       9,659,457       8,745,433  

General and administrative expenses

    2,560,487       2,072,195       7,675,622       6,125,151  

Research and development expenses

    1,102,942       1,066,493       3,557,437       3,217,410  

Total operating expenses

    7,113,737       6,310,345       20,892,516       18,087,994  
                                 

OPERATING INCOME

    1,822,936       2,578,754       3,534,770       6,063,068  
                                 

REMEASUREMENT GAIN ON ACQUISITION OF EQUITY METHOD INVESTEE

                3,951,550        

INTEREST INCOME

    15,925       10,676       36,777       95,852  

INTEREST EXPENSE

    (23,784 )     (3,044 )     (34,079 )     (10,661 )

INCOME BEFORE INCOME TAX EXPENSE

    1,815,077       2,586,386       7,489,018       6,148,259  
                                 

INCOME TAX EXPENSE

    604,314       276,338       1,260,437       929,588  

NET INCOME

    1,210,763       2,310,048       6,228,581       5,218,671  
                                 

NET INCOME ATTRIBUTABLE TO NON-CONTROLLING INTERESTS

    210,596       256,132       551,808       589,781  

NET INCOME ATTRIBUTABLE TO NTIC

  $ 1,000,167     $ 2,053,916     $ 5,676,773     $ 4,628,890  
                                 

NET INCOME ATTRIBUTABLE TO NTIC PER COMMON SHARE:

                               

Basic

  $ 0.11     $ 0.23     $ 0.62     $ 0.51  

Diluted

  $ 0.11     $ 0.21     $ 0.59     $ 0.47  
                                 

WEIGHTED AVERAGE COMMON SHARES ASSUMED OUTSTANDING:

                               

Basic

    9,227,912       9,109,861       9,216,216       9,107,243  

Diluted

    9,578,797       9,972,000       9,682,646       9,829,052  
                                 

CASH DIVIDENDS DECLARED PER COMMON SHARE

  $ 0.07     $ 0.065     $ 0.21     $ 0.13  

 

See notes to consolidated financial statements.

 

4

 

 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED MAY 31, 2022 AND 2021


 

   

Three Months Ended May 31,

   

Nine Months Ended May 31,

 
   

2022

   

2021

   

2022

   

2021

 

NET INCOME

  $ 1,210,763     $ 2,310,048     $ 6,228,581     $ 5,218,671  

OTHER COMPREHENSIVE INCOME– FOREIGN CURRENCY TRANSLATION ADJUSTMENT

    (1,554,022 )     262,267       (1,936,791 )     757,273  

COMPREHENSIVE INCOME

    (343,259 )     2,572,315       4,291,790       5,975,944  

COMPREHENSIVE INCOME  ATTRIBUTABLE TO NON- CONTROLLING INTERESTS

    (181,283 )     266,771       (473,385 )     654,551  

COMPREHENSIVE INCOME ATTRIBUTABLE TO NTIC

  $ (161,976 )   $ 2,305,544     $ 4,765,175     $ 5,321,393  

 

See notes to consolidated financial statements.

 

5

 

 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED MAY 31, 2022 AND 2021


 

   

STOCKHOLDERS EQUITY THREE MONTHS ENDED MAY 31, 2022 AND 2021

                 
                                   

Accumulated

                 
                   

Additional

           

Other

   

Non-

         
   

Common Stock

   

Paid-in

   

Retained

   

Comprehensive

   

Controlling

   

Total

 
   

Shares

   

Amount

   

Capital

   

Earnings

   

Income (Loss)

   

Interests

   

Equity

 
                                                         

BALANCE AS OF FEBRUARY 28, 2022

    9,221,517     $ 184,430     $ 19,379,032     $ 50,361,068     $ (3,858,689 )   $ 3,371,926     $ 69,437,767  

Stock issued for employee stock purchase plan

    2,966       59       35,054                         35,113  

Stock options exercised

    8,000       161       59,279                         59,440  

Stock option expense

                232,883                         232,883  

Dividends paid to stockholders

                      (646,274 )                 (646,274 )

Dividend received by non-controlling interest

                                  (100,000 )     (100,000 )

Net income

                      1,000,167             210,596       1,210,763  

Other comprehensive gain

                            (1,524,711 )     (29,311 )     (1,554,022 )

BALANCE AS OF MAY 31, 2022

    9,232,483     $ 184,650     $ 19,706,248     $ 50,714,961     $ (5,383,400 )   $ 3,453,211     $ 68,675,670  
                                                         

BALANCE AS OF FEBRUARY 28, 2021

    9,104,636     $ 182,093     $ 17,793,646     $ 44,455,982     $ (2,969,563 )   $ 3,232,806     $ 62,694,964  

Stock issued for employee stock purchase plan

    5,225       104       38,038                         38,142  

Stock option expense

                160,834                         160,834  

Dividends paid to stockholders

                      (592,141 )                 (592,141 )

Net income

                      2,053,916             256,132       2,310,048  

Other comprehensive gain

                            251,628       10,639       262,267  

BALANCE AS OF MAY 31, 2021

    9,109,861     $ 182,197     $ 17,992,518     $ 45,917,757     $ (2,717,935 )   $ 3,499,577     $ 64,874,114  

 

   

STOCKHOLDERS EQUITY NINE MONTHS ENDED MAY 31, 2022 AND 2021

                 
                                   

Accumulated

                 
                   

Additional

           

Other

   

Non-

         
   

Common Stock

   

Paid-in

   

Retained

   

Comprehensive

   

Controlling

   

Total

 
   

Shares

   

Amount

   

Capital

   

Earnings

   

Income (Loss)

   

Interests

   

Equity

 
                                                         

BALANCE AS OF AUGUST 31, 2021

    9,184,811     $ 183,696     $ 18,736,268     $ 46,973,094     $ (3,525,030 )   $ 3,382,553     $ 65,750,581  

Stock issued for employee stock purchase plan

    5,601       112       73,533                         73,645  

Stock options exercised

    42,071       842       197,798                         198,640  

Stock option expense

                698,649                         698,649  

Dividends paid to stockholders

                      (1,934,906 )                 (1,934,906 )

Dividend received by non-controlling interest

                                  (402,729 )     (402,729 )

Net income

                      5,676,773             551,808       6,228,581  

Other comprehensive income

                            (1,858,370 )     (78,421 )     (1,936,791 )

BALANCE AS OF MAY 31, 2022

    9,232,483     $ 184,650     $ 19,706,248     $ 50,714,961     $ (5,383,400 )   $ 3,453,211     $ 68,675,670  
                                                         

BALANCE AS OF AUGUST 31, 2020

    9,099,990     $ 182,000     $ 17,415,043     $ 42,472,810     $ (3,410,438 )   $ 3,045,026     $ 59,704,441  

Stock issued for employee stock purchase plan

    9,871       197       74,137                         74,334  

Stock option expense

                503,338                         503,338  

Dividends paid to stockholders

                      (1,183,943 )                 (1,183,943 )

Dividend received by non-controlling interest

                                  (200,000 )     (200,000 )

Net income

                      4,628,890             589,781       5,218,671  

Other comprehensive income

                            692,503       64,770       757,273  

BALANCE AS OF MAY 31, 2021

    9,109,861     $ 182,197     $ 17,992,518     $ 45,917,757     $ (2,717,935 )   $ 3,499,577     $ 64,874,114  

 

See notes to consolidated financial statements.

 

6

 

 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

FOR THE NINE MONTHS ENDED MAY 31, 2022 AND 2021


 

   

Nine Months Ended May 31,

 
   

2022

   

2021

 

CASH FLOWS FROM OPERATING ACTIVITIES:

               

Net income

  $ 6,228,581     $ 5,218,671  

Adjustments to reconcile net income to net cash provided by operating activities:

               

Stock-based compensation

    698,649       503,338  

Change in allowance for doubtful accounts

          30,000  

Depreciation expense

    722,443       681,484  

Amortization expense

    474,121       151,710  

Remeasurement gain on acquisition of equity method investee

    (3,951,550 )      

Equity in income from joint ventures

    (3,662,178 )     (5,779,260 )

Dividends received from joint ventures

    5,723,176       3,505,455  

Deferred income taxes

    152,372       (8,526 )

Changes in current assets and liabilities:

               

Receivables:

               

Trade, excluding joint ventures

    (1,348,254 )     (2,904,707 )

Trade, joint ventures

    (232,364 )     (564,149 )

Fees for services provided to joint ventures

    261,913       (499,954 )

Income taxes

    (134,942 )     (223,024 )

Inventories

    (2,093,668 )     (177,927 )

Prepaid expenses and other

    (635,478 )     (223,457 )

Accounts payable

    908,605       703,100  

Income tax payable

    (420,529 )     (162,615 )

Accrued liabilities

    (912,803 )     803,555  

Net cash provided by operating activities

    1,778,094       1,053,695  
                 

CASH FLOWS FROM INVESTING ACTIVITIES:

               

Acquisition of Zerust India business, net of cash acquired (see Note 3)

    (5,062,003 )      

Purchase of available for sale securities

    (941 )     (800,000 )

Proceeds from the sale of available for sale securities

          1,219,670  

Investment in joint venture

    (341,392 )      

Purchases of property and equipment

    (961,704 )     (723,441 )

Investments in patents

    (164,994 )     (96,009 )

Net cash used in investing activities

    (6,531,034 )     (399,780 )
                 

CASH FLOWS FROM FINANCING ACTIVITIES:

               

Dividend received by non-controlling interest

    (402,729 )     (200,000 )

Proceeds from line of credit

    4,700,000        

Dividends paid on NTIC common stock

    (1,934,906 )     (1,183,943 )

Proceeds from the exercise of stock options

    198,640        

Proceeds from employee stock purchase plan

    73,645       74,334  

Net cash provided by (used in) financing activities

    2,634,650       (1,309,609 )
                 

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

    560,918       133,585  
                 
                 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

    (1,557,372 )     (522,109 )

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

    7,680,641       6,403,032  
                 

CASH AND CASH EQUIVALENTS AT END OF PERIOD

  $ 6,123,269     $ 5,880,923  

 

See notes to consolidated financial statements.

 

7

 

 

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


 

 

1.         INTERIM FINANCIAL INFORMATION

 

In the opinion of management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, which are of a normal recurring nature, and present fairly the consolidated financial position of Northern Technologies International Corporation and its subsidiaries (the Company) as of May 31, 2022 and August 31, 2021, the results of the Company’s operations for the three and nine months ended May 31, 2022 and 2021, the changes in stockholders’ equity for the three and nine months ended May 31, 2022 and 2021, and the Company’s cash flows for the nine months ended May 31, 2022 and 2021, in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP).

 

These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in the Company’s annual report on Form 10-K for the fiscal year ended August 31, 2021. These consolidated financial statements also should be read in conjunction with the “Managements Discussion and Analysis of Financial Condition and Results of Operations” section appearing in this report.

 

Operating results for the three and nine months ended May 31, 2022 are not necessarily indicative of the results that may be expected for the full fiscal year ending August 31, 2022.

 

The Company evaluates events occurring after the date of the consolidated financial statements requiring recording or disclosure in the consolidated financial statements.

 

Impact of COVID-19 Pandemic

 

As a result of the novel coronavirus (COVID-19) pandemic and related government mandated restrictions on the Company’s business as well as the businesses of its joint ventures, customers and suppliers, disruption to the Company’s business and the manufacture and sale of its products and services continued to occur during the first nine months of fiscal 2022 and is expected to continue during the remainder of fiscal 2022 and into fiscal 2023. In the first nine months of fiscal 2022, the Company continued to be impacted by shipping issues, including freight container shortages, shipping delays, and increased costs, and supply chain issues, including longer lead times and raw material cost increases.

 

 

2.          ACCOUNTING PRONOUNCEMENTS

 

Recently Issued Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, Measurement of Credit Losses on Financial Instruments, which revises guidance for the accounting for credit losses on financial instruments within its scope, and in November 2018, issued ASU No. 2018-19 and in April 2019, issued ASU No. 2019-04 and in May 2019, issued ASU No. 2019-05, and in November 2019, issued ASU No. 2019-11, which amended the standard. The new standard introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments and modifies the impairment model for available-for-sale debt securities. The new approach to estimating credit losses (referred to as the current expected credit losses model) applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases and off-balance-sheet credit exposures. This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company is still evaluating the impact of this ASU.

 

8

 

Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on the Company’s consolidated financial position or operating results.

 

 

3.         BUSINESS COMBINATION

 

On September 21, 2021, the Company announced that it acquired the remaining 50% ownership interest in its Indian joint venture, Harita-NTI Limited (Zerust India), for $6,250,000 in cash, effective as of September 1, 2021, the date the Company obtained control. Prior to September 1, 2021, the Company owned 50% of the outstanding capital stock of Zerust India. The Company had historically accounted for this investment under the equity method of accounting. This purchase was funded with cash on hand and borrowings under the Company’s revolving line of credit. The Company undertook the acquisition to enhance its Zerust business in India.

 

The purchase price of $6,250,000 was funded with cash on hand and borrowings under the Company’s revolving line of credit, which was increased in connection with the transaction to $5,000,000.

 

Because the Company increased its ownership interest in Zerust India to 100%, the acquisition of Zerust India has been accounted for in accordance with Accounting Standards Codification (ASC) 805, Business Combinations, by using the acquisition method of accounting. Effective September 1, 2021, Zerust India became a consolidated subsidiary within the Company’s financial statements.

 

The following table summarizes the purchase price allocation that includes the fair values of the separately identifiable assets acquired and liabilities assumed as of September 1, 2021:

 

Cash and cash equivalents

 $1,187,997 

Trade account receivable

  1,954,769 

Inventories

  886,650 

Prepaid expenses and other

  396,545 

Property, plant and equipment

  219,077 

Operating lease, right of use asset

  355,000 

Customer relationships

  6,347,000 

Goodwill

  4,782,376 

Current liabilities

  (1,370,314)

Deferred tax liability

  (1,904,100)

Operating lease liability

  (355,000)
 

Net assets acquired

 $12,500,000 

Less:

     
 

Fair value of previously held equity method investment

  (1,637,362)
 

Cumulative foreign currency translation

  (661,088)
 

Gain recognized on acquisition

  (3,951,550)
    (6,250,000)

Cash paid for acquisition

 $6,250,000 

 

9

 

The excess of the fair value of purchase consideration over the fair value of net tangible and identifiable intangible assets acquired was recorded as goodwill. The fair values assigned to tangible and identifiable intangible assets acquired and liabilities assumed are based on management’s estimates and assumptions. The fair values of assets acquired and liabilities assumed may be subject to change as additional information is received.

 

The fair value of the intangible asset associated with customer relationships was estimated using a discounted cash flow method with the application of the multi-period excess earnings method. Under this method, an intangible asset’s fair value is equal to the present value of the incremental after-tax cash flows attributable to only the subject intangible asset after deducting contributory asset charges.

 

The rate used to discount the estimated future net cash flows to their present values for the intangible assets was based upon a weighted average cost of capital calculation. The discount rate was determined after consideration of market rates of return on debt and equity capital, the weighted average return on invested capital and the risk associated with achieving forecasted sales related to the assets acquired from Zerust India. The weighted average discount rate used to determine the fair value of the customer relationships was 15.3%.

 

The amortization period for the intangible assets is 15 years. The intangible assets are being amortized on a straight-line basis, which is consistent with the pattern that the economic benefits of the intangible assets are expected to be utilized based upon estimated cash flows generated from such asset. Goodwill associated with the acquisition was primarily attributable to the expansion opportunity of the Company’s Zerust business in India.

 

Authoritative guidance on accounting for business combinations requires that an acquirer re-measure its previously held equity interest in the acquisition at its acquisition date fair value and recognize the resulting gain or loss in earnings. As such, since the Company acquired the remaining 50% ownership interest of Zerust India effective September 1, 2021, the Company recognized a gain of $3,951,550 during the nine months ended May 31, 2022. This gain is included in “Remeasurement gain on acquisition of equity method investee” on the Company’s consolidated statements of operations for the nine months ended May 31, 2022.

 

The Company has included the financial results of Zerust India in the consolidated financial statements from September 1, 2021. Net revenue and net income related to Zerust India since the date of acquisition totaled $7,260,964 and $664,775, respectively. The transaction costs associated with the acquisition were approximately $0 and $115,000, respectively, and are recorded in general and administrative expense as incurred during the three and nine months ended May 31, 2022.

 

Unaudited consolidated pro forma information assuming the acquisition had occurred on September 1, 2020 for the three and nine months ended May 31, 2021 would have an increase in net sales $2,405,098 and $6,697,005, respectively. Unaudited pro forma net income, assuming the acquisition had occurred on September 1, 2020, for the three and nine months ended May 31, 2021 was not considered material to the Company’s consolidated net income. The unaudited consolidated pro forma combined financial information does not purport to be indicative of the results which would have been obtained had the acquisition been completed as of the beginning of the earliest period presented or of results that may be obtained in the future. In addition, they do not include any benefits that may result from the acquisition due to synergies that may be derived from the elimination of any duplicative costs.

 

10

 
 
 

4.         INVENTORIES

 

Inventories consisted of the following:

 

  

May 31, 2022

  

August 31, 2021

 

Production materials

 $4,946,106  $4,453,688 

Finished goods

  8,920,123   6,660,519 
  $13,866,229  $11,114,207 

 

 

5.         PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following:

 

  

May 31, 2022

  

August 31, 2021

 

Land

 $310,365  $310,365 

Buildings and improvements

  14,098,634   13,149,258 

Machinery and equipment

  5,569,711   5,453,679 
   19,978,710   18,913,302 

Less accumulated depreciation

  (7,907,433)  (7,091,844)
  $12,071,277  $11,821,458 

 

 

6.         PATENTS AND TRADEMARKS, NET

 

Patents and trademarks, net consisted of the following:

 

  

May 31, 2022

  

August 31, 2021

 

Patents and trademarks

 $3,183,500  $3,018,507 

Less accumulated amortization

  (2,465,705)  (2,308,935)
  $717,795  $709,572 

 

 

7.         INVESTMENTS IN JOINT VENTURES

 

The consolidated financial statements of the Company’s foreign joint ventures are initially prepared using the accounting principles accepted in the respective joint ventures’ countries of domicile. Amounts related to foreign joint ventures reported in the below tables and the accompanying consolidated financial statements have subsequently been adjusted to conform with U.S. GAAP in all material respects. All material profits on sales recorded that remain on the consolidated balance sheet from the Company to its joint ventures and from joint ventures to other joint ventures have been eliminated for financial reporting purposes.

 

Financial information from the audited and unaudited financial statements of the Company’s joint venture in Germany, Excor Korrosionsschutz – Technologien und Produkte GmbH (EXCOR), and all the Company’s other joint ventures are summarized as follows:

 

11

 
 
  

As of May 31, 2022

 
  

Total

  

EXCOR

  

All Other

 

Current assets

 $55,305,950  $25,677,287  $29,628,663 

Total assets

  59,037,744   27,727,623   31,310,121 

Current liabilities

  13,289,392   2,978,114   10,311,279 

Noncurrent liabilities

  1,223,185      1,223,185 

Joint ventures’ equity

  44,601,335   24,749,509   19,851,826 

Northern Technologies International Corporation’s share of joint ventures’ equity

  22,194,433   12,374,756   9,819,677 

Northern Technologies International Corporation’s share of joint ventures’ undistributed earnings

  20,844,284   12,343,851   8,500,433 

 

  

Three Months Ended May 31, 2022

 
  

Total

  

EXCOR

  

All Other

 

Net sales

 $26,594,077  $10,397,916  $16,196,160 

Gross profit

  10,626,570   4,990,697   5,635,873 

Net income

  2,714,979   1,654,389   1,060,590 

Northern Technologies International Corporation’s share of equity in income from joint ventures

  1,364,597   824,784   539,813 

Northern Technologies International Corporation’s dividends received from joint ventures

  252,000      252,000 

 

  

Nine Months Ended May 31, 2022

 
  

Total

  

EXCOR

  

All Other

 

Net sales

 $78,218,839  $31,010,578  $47,208,261 

Gross profit

  31,504,531   15,118,133   16,386,398 

Net income

  7,344,175   4,646,123   2,698,052 

Northern Technologies International Corporation’s share of equity in income from joint ventures

  3,662,178   2,324,605   1,337,572 

Northern Technologies International Corporation’s dividends received from joint ventures

  5,723,176   4,255,200   1,467,976 

 

  

As of August 31, 2021

 
  

Total

  

EXCOR

  

All Other(1)

 

Current assets

 $69,394,796  $33,886,655  $35,508,141 

Total assets

  73,814,402   36,211,520   37,602,882 

Current liabilities

  16,366,398   5,386,377   10,980,021 

Noncurrent liabilities

  1,455,524      1,455,524 

Joint ventures’ equity

  55,992,480   30,825,144   25,167,336 

Northern Technologies International Corporation’s share of joint ventures’ equity

  27,623,768   15,412,574   12,211,194 

Northern Technologies International Corporation’s share of joint ventures’ undistributed earnings

  24,702,778   14,697,490   10,005,288 

 

12

 
  

Three Months Ended May 31, 2021

 
  

Total

  

EXCOR

  

All Other(1)

 

Net sales

 $31,959,539  $12,103,263  $19,856,276 

Gross profit

  14,280,775   6,863,786   7,416,989 

Net income

  4,051,518   2,068,326   1,983,192 

Northern Technologies International Corporation’s share of equity in income from joint ventures

  2,033,536   1,039,576   993,960 

Northern Technologies International Corporation’s dividends received from joint ventures

  181,952      181,952 

 

  

Nine Months Ended May 31, 2021

 
  

Total

  

EXCOR

  

All Other(1)

 

Net sales

 $87,795,284  $32,196,843  $55,598,441 

Gross profit

  39,802,014   18,661,980   21,140,034 

Net income

  11,540,949   6,351,721   5,189,228 

Northern Technologies International Corporation’s share of equity in income from joint ventures

  5,779,260   3,182,691   2,596,569 

Northern Technologies International Corporation’s dividends received from joint ventures

  3,505,455   1,809,900   1,695,555 

__________

(1)         Includes Zerust India since Zerust India was not a consolidated subsidiary of the Company as of August 31, 2021 or May 31, 2021. See Note 3 entitled “Business Combination.”

 

 

8.         INTANGIBLE ASSET, NET

 

Intangible asset, net consisted of the following as of May 31, 2022:

 

  

May 31, 2022

  

August 31, 2021

 

Customer relationships

 $6,347,000  $ 

Less accumulated amortization

  (317,350)   

Net Carrying Amount

 $6,029,650  $ 

 

The customer relationships were established as a part of purchase accounting related to our Zerust India acquisition. See Note 3 entitled “Business Combination.” The Company amortizes the intangible asset related to the customer relationships using the straight-line method over the estimated useful lives of the asset, which is 15 years. Total amortization expense was $105,783 and $317,350 for the three and nine months ended May 31, 2022, respectively. Amortization expense is estimated to be $423,000 in each of the next five fiscal years.         

 

 

9.         CORPORATE DEBT

 

The Company has a revolving line of credit with PNC Bank, National Association (PNC Bank) of $7,000,000 as of May 31, 2022, which will decrease to $5,000,000 effective August 16, 2022. The line of credit has a maturity date of January 7, 2023 and bears interest at an annual rate equal to the daily Bloomberg Short-Term Bank Yield Index plus 250 basis points (2.50%). The line of credit is governed under an Amended and Restated Loan Agreement dated August 31, 2021.

 

On May 20, 2022, to maintain financial flexibility, the Company issued an Amended and Restated Revolving Line of Credit Note to PNC Bank, which increased the Company’s line of credit from $5,000,000 to $7,000,000 until August 16, 2022, at which time the line of credit will go back to $5,000,000 until its expiration date on January 7, 2023. Additionally, on January 4, 2022, the Company issued an Amended and Restated Revolving Line of Credit Note, which extended the maturity date to January 7, 2023 and revised the rate at which amounts outstanding under the line of credit bear interest to equal a per annum rate equal to the daily Bloomberg Short-Term Bank Yield Index plus 250 basis points (2.50%). The other material terms of the line of credit were not affected by these amendments or other immaterial amendments that have been executed since the execution of the Amended and Restated Loan Agreement dated August 31, 2021.

 

13

 

Borrowings of $4,700,000 were outstanding under the line of credit as of May 31, 2022 and no amounts were outstanding as of August 31, 2021. Such outstanding borrowings were used primarily to fund the Company’s acquisition of the remaining ownership interest of Zerust India. The average interest rate during each of the three and nine months ended May 31, 2022 was 2.92% and 2.69%, respectively.

 

The obligations of the Company under the loan agreement are secured by a lien on all of the Company’s personal property, excepting certain liens consented to in writing by PNC. The loan agreement contains covenants, including affirmative financial covenants, such as the maintenance of a minimum fixed charge coverage ratio of 1.10:1.00, and negative covenants, which, among other things, limit the incurrence of additional indebtedness, loans and equity investments, disposition of assets, mergers and consolidations and other matters customarily restricted in such agreements. As of May 31, 2022, the Company was in compliance with all debt covenants.

 

As of May 31, 2022 and August 31, 2021, the Company did not have any letters of credit outstanding with respect to the letter of credit sub-facility available under the revolving line of credit with PNC Bank. As of May 31, 2022 and August 31, 2021, the Company had $72,418 of letters of credit with JP Morgan Chase Bank that are performance based and set to expire between 2021 and 2022.

 

 

10.         STOCKHOLDERS EQUITY

 

During the nine months ended May 31, 2022, the Company’s Board of Directors declared cash dividends on the following dates in the following amounts to holders of record of the Company’s common stock as of the following record dates:

 

Declaration Date

 

Amount

 

Record Date

 

Payable Date

October 20, 2021

  $ 0.07  

November 3, 2021

 

November 17, 2021

January 21, 2022

  $ 0.07  

February 2, 2022

 

February 16, 2022

April 22, 2022

  $ 0.07  

May 4, 2022

 

May 18, 2022

 

On April 23, 2020, the Company announced the temporary suspension of its quarterly cash dividend pending clarity on the financial impact of COVID-19 on the Company. On January 15, 2021, the Company announced the reinstatement of its quarterly cash dividend. During the nine months ended May 31, 2021, the Company’s Board of Directors declared cash dividends on the following dates in the following amounts to holders of record of the Company’s common stock as of the following record dates:

 

Declaration Date

 

Amount

 

Record Date

 

Payable Date

January 15, 2021

  $ 0.065  

February 3, 2021

 

February 17, 2021

April 23, 2021

  $ 0.065  

May 5, 2021

 

May 19, 2021

 

During the nine months ended May 31, 2022 and 2021, the Company repurchased no shares of its common stock.

 

During the nine months ended May 31, 2022, the Company granted stock options under the Northern Technologies International Corporation 2019 Stock Incentive Plan (as amended, the 2019 Plan) to purchase an aggregate of 174,840 shares of its common stock to various employees and directors. The weighted average per share exercise price of the stock options is $16.97. The exercise price of the stock options is equal to the fair market value of the Company’s common stock on the date of grant. During the nine months ended May 31, 2022, stock options to purchase an aggregate of 51,218 shares of common stock were exercised at a weighted average exercise price of $6.60 per share, resulting in the net issuance of 42,071 shares of common stock since some of the options were exercised on a net cashless exercise basis.

 

14

 

During the nine months ended May 31, 2021, the Company granted stock options under the 2019 Plan to purchase an aggregate of 419,874 shares of its common stock to various employees and directors. The weighted average per share exercise price of the stock options is $8.24. The exercise price of the stock options is equal to the fair market value of the Company’s common stock on the date of grant. During the nine months ended May 31, 2021, no stock options to purchase common stock were exercised.

 

The Company issued 2,636 and 4,646 shares of common stock on September 1, 2021 and 2020, respectively, under the Northern Technologies International Corporation Employee Stock Purchase Plan (ESPP). The Company issued 2,966 and 5,225 shares of common stock on March 1, 2022 and 2021, respectively, under the ESPP. The ESPP is compensatory for financial reporting purposes. As of May 31, 2021, 69,220 shares of common stock remained available for sale under the ESPP.

 

 

11.         NET INCOME PER COMMON SHARE

 

Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding. Diluted net income per share assumes the exercise of stock options using the treasury stock method, if dilutive.

 

The following is a reconciliation of the net income per share computation for the three and nine months ended May 31, 2022 and 2021:

 

  

Three Months Ended May 31,

  

Nine Months Ended May 31,

 

Numerator:

 

2022

  

2021

  

2022

  

2021

 

Net income attributable to NTIC

 $1,000,167  $2,053,916  $5,676,773  $4,628,890 
                 

Denominator:

                

Basic – weighted shares outstanding

  9,227,912   9,109,861   9,216,216   9,107,243 

Weighted shares assumed upon exercise of stock options

  350,886   862,139   466,430   721,809 

Diluted – weighted shares outstanding

  9,578,797   9,972,000   9,682,646   9,829,052 

Basic net income per share:

 $0.11  $0.23  $0.62  $0.51 

Diluted net income per share:

 $0.11  $0.21  $0.59  $0.47 

 

The dilutive impact summarized above relates to the periods when the average market price of the Company’s common stock exceeded the exercise price of the potentially dilutive option securities granted. Net income per common share was based on the weighted average number of common shares outstanding during the periods when computing basic net income per share. When dilutive, stock options are included as equivalents using the treasury stock market method when computing the diluted net income per share. Excluded from the computation of diluted net income per share for the three and nine months ended May 31, 2022 were options outstanding to purchase 327,793 shares of common stock. Excluded from the computation of diluted net income per share for the three and nine months ended May 31, 2021 were options outstanding to purchase 136,221 shares of common stock.

 

 

12.         STOCK-BASED COMPENSATION

 

The Company has three stock-based compensation plans under which stock options or other stock-based awards have been granted: the Northern Technologies International Corporation Amended and Restated 2019 Stock Incentive Plan, the Northern Technologies International Corporation Amended and Restated 2007 Stock Incentive Plan (2007 Plan) and the Northern Technologies International Corporation Employee Stock Purchase Plan. The 2019 Plan replaced the 2007 Plan with respect to future grants; and, therefore, no further awards may be made under the 2007 Plan. The Compensation Committee of the Board of Directors and the Board of Directors administer these plans.

 

15

 

The 2019 Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, stock unit awards, performance awards, and stock bonuses to eligible recipients to enable the Company and its subsidiaries to attract and retain qualified individuals through opportunities for equity participation in the Company and to reward those individuals who contribute to the achievement of the Company’s economic objectives. On January 15, 2021, the Company’s stockholders approved certain amendments to the 2019 Plan, including an increase in the number of shares of common stock available for issuance under the plan by an additional 800,000 shares. Subject to adjustment as provided in the 2019 Plan, up to a maximum of 1,600,000 shares of the Company’s common stock are issuable under the 2019 Plan. Options granted generally have a term of ten years and become exercisable over a one- or three-year period beginning on the one-year anniversary of the date of grant. Options are granted at per share exercise prices equal to the market value of the Company’s common stock on the date of grant. The Company issues new shares upon the exercise of options. As of May 31, 2022, options to purchase an aggregate of 895,484 shares of the Company’s common stock were outstanding under the 2019 Plan and 704,516 shares of the Company’s common stock remain available for grant under the 2019 Plan. As of May 31, 2022, options to purchase an aggregate of 654,789 shares of the Company’s common stock were outstanding under the 2007 Plan.

 

The Company granted options to purchase an aggregate of 174,840 and 419,874 shares of its common stock during the nine months ended May 31, 2022 and 2021, respectively.  The fair value of option grants is determined at the date of grant using the Black-Scholes option pricing model with the assumptions listed below.  The Company recognized compensation expense of $232,883 and $698,649 during the three and nine months ended May 31, 2022, respectively, and compensation expense of $160,834 and $503,338 during the three and nine months ended May 31, 2021, respectively, related to the options that vested during such time period.  As of May 31, 2022, the total compensation cost for non-vested options not yet recognized in the Company’s consolidated statements of operations was $1,242,602.  Stock-based compensation expense of $232,883 is expected through the remainder of fiscal 2022 and $671,526 and $338,193 is expected to be recognized during fiscal 2023 and fiscal 2024, respectively, based on outstanding options as of May 31, 2022.  Future option grants will impact the compensation expense recognized. Stock-based compensation expense is included in general and administrative expense on the consolidated statements of operations.

 

The fair value of each option grant is estimated on the grant date using the Black-Scholes option pricing model with the following assumptions and results for the grants:

 

  

Three and Nine Months Ended May 31,

 
  

2022

  

2021

 

Dividend yield

  1.65%  2.37%

Expected volatility

  45.4%  45.6%

Expected life of option (in years)

  10   10 

Average risk-free interest rate

  0.77%  0.28%

 

The weighted average per share fair value of options granted during the nine months ended May 31, 2022 and 2021 was $7.29 and $3.12, respectively. The weighted average remaining contractual life of the options outstanding as of May 31, 2022 and 2021 was 6.02 years and 6.40 years, respectively.

 

 

13.         SEGMENT AND GEOGRAPHIC INFORMATION

 

Segment Information

 

The Company’s chief operating decision maker is its Chief Executive Officer. The Company’s business is organized into two reportable segments: ZERUST® and Natur-Tec®. The Company has been selling its proprietary ZERUST® rust and corrosion inhibiting products and services to the automotive, electronics, electrical, mechanical, military and retail consumer markets for over 45 years and, more recently, has targeted and expanded into the oil and gas industry. The Company also sells a portfolio of bio-based and compostable (fully biodegradable) polymer resins and finished products under the Natur-Tec® brand.

 

16

 

The following table sets forth the Company’s net sales for the three and nine months ended May 31, 2022 and 2021 by segment:

 

  

Three Months Ended May 31,

  

Nine Months Ended May 31,

 
  

2022

  

2021

  

2022

  

2021

 

ZERUST® net sales

 $14,446,832  $12,378,215  $41,988,394  $32,882,882 

Natur-Tec® net sales

  4,518,089   3,040,309   11,918,579   8,097,636 

Total net sales

 $18,964,921  $15,418,524  $53,906,973  $40,980,518 

 

The following table sets forth the Company’s cost of goods sold for the three and nine months ended May 31, 2022 and 2021 by segment:

 

  

Three Months Ended May 31,

  

Nine Months Ended May 31,

 
  

2022

  

% of Product Sales*

  

2021

  

% of Product Sales*

  

2022

  

% of Product Sales*

  

2021

  

% of Product Sales*

 

Direct cost of goods sold

                                

ZERUST®

 $8,409,392   58.2% $7,091,220   57.3% $25,267,333   60.2% $18,928,272   57.6%

Natur-Tec®

  3,432,152   76.0%  2,251,996   74.1%  9,129,686   76.6%  5,703,807   70.4%

Indirect cost of goods sold

  881,289      809,366      2,580,601      2,365,503    

Total net cost of goods sold

 $12,722,833      $10,152,582      $36,977,620      $26,997,582     

 


*         The percent of segment sales is calculated by dividing the direct cost of goods sold for each individual segment category by the net sales for each segment category.

 

The Company utilizes product net sales and direct and indirect cost of goods sold for each product in reviewing the financial performance of a product type. Further allocation of Company expenses or assets, aside from amounts presented in the tables above, is not utilized in evaluating product performance, nor does such allocation occur for internal financial reporting.

 

Geographic Information

 

Net sales by geographic location for the three and nine months ended May 31, 2022 and 2021 were as follows:

 

  

Three Months Ended May 31,

  

Nine Months Ended May 31,

 
  

2022

  

2021

  

2022

  

2021

 

Inside the U.S.A. to unaffiliated customers

 $6,884,726  $6,717,886  $18,157,010  $16,198,372 

Outside the U.S.A. to:

                

Joint ventures in which the Company is a shareholder directly and indirectly

  528,665   1,253,919   2,252,618   2,361,165 

Unaffiliated customers

  11,551,530   7,446,719   33,497,345   22,420,981 
  $18,964,921  $15,418,524  $53,906,973  $40,980,518 

 

Net sales by geographic location are based on the location of the customer.

 

17

 

Fees for services provided to joint ventures by geographic location as a percentage of total fees for services provided to joint ventures during the three and nine months ended May 31, 2022 and 2021 were as follows:

 

  

Three Months Ended May 31,

 
  

2022

  

% of Total Fees for Services Provided to Joint Ventures

  

2021

  

% of Total Fees for Services Provided to Joint Ventures

 

Germany

 $204,316   15.4% $232,026   14.6%

Poland

  171,181   12.9%  226,174   14.2%

Japan

  168,075   12.6%  200,270   12.6%

France

  123,869   9.3%  119,172   7.5%

Sweden

  130,681   9.8%  127,710   8.0%

United Kingdom

  89,363   6.7%  113,886   7.2%

Thailand

  95,574   7.2%  108,842   6.8%

Finland